Palindrome Pharma, a new Canadian pharmaceutical company, has launched with a focus on biosimilar medicines to improve access to biologic therapies and support a sustainable healthcare system. The company aims to build a diverse portfolio through partnerships, emphasizing patient access, quality, healthcare sustainability, and strong collaborations with stakeholders. This launch is significant as biosimilars offer more treatment options and cost savings for the growing demand in biologic medicines in Canada. Palindrome Pharma plans to establish itself as a trusted partner in the Canadian healthcare market over the long term.
Palindrome Pharma's launch in Canada is presented here with Pluang's health sector market snapshot as of Oct 07, 2026 08:51 WIB: Among 100 priced US health stocks, 36 rose and 61 fell. Notably, CTXR traded at USD 0.48 with a 7.65% decline and a dominant 98% buy order activity, contrasting with BNGO which rose 7.27% to USD 1.55 and saw 100% buy orders. Moderna (MRNA) stood at USD 187.86, down 7.55%, with a longer typical hold time of 59 days compared to CTXR's 17 days.
The Reserve Bank of India raised its key policy rate by 25 basis points to 5.5%, marking the first increase since 2023. This move aims to curb rising inflation, which has been increasing for 10 consecutive months and currently stands above the RBI's ...
Temasek, Singapore's state-owned investment firm, sees the biggest market risk as a potential reversal in the artificial intelligence (AI) trade, which currently supports U.S. stock highs despite rising Treasury yields. Factors like tighter regulatio...
On October 6, U.S. spot Bitcoin ETFs attracted $118.8 million in net inflows, driven mainly by IBIT which contributed $122 million, making it the largest positive inflow among Bitcoin ETFs. In contrast, Ethereum ETFs experienced $201.9 million in net...
U.S. spot Bitcoin exchange-traded funds (ETFs) recorded net inflows of $118.8 million on October 6, reversing a prior session's outflow. Over five days, total inflows reached $172.9 million, with BlackRock's iShares Bitcoin Trust leading at $122 mill...
Abstract, an Ethereum layer-2 blockchain focused on consumer applications, will shut down on December 15 after its parent company Igloo lost tens of millions of dollars funding it. Despite processing over 325 million transactions and hosting $6 billi...
